20260605_MEDC_Laporan Informasi dan Fakta Material_32097532_lamp1.pdf

 PT Medco Energi Internasional Tbk                                     Tel +62-21 2995 3000
 The Energy 53rd Fl., SCBD Area Lot 11 A                               Fax +62-21 2995 3001
 Jl. Jend. Sudirman, Jakarta 12190                                     www.medcoenergi.com




                            MedcoEnergi Holds 2026 Annual General Meeting of Shareholders

Jakarta, 4 June 2026 – PT Medco Energi Internasional Tbk ("MedcoEnergi" or the "Company") today held its
Annual General Meeting of Shareholders ("AGMS"), which approved the 2025 Annual Report and ratified the
2025 audited Financial Statements, and accepted the Report on the Management Duties of the Board of
Directors and the Supervisory Duties of the Board of Commissioners of the Company for fiscal year 2025.

The shareholders approved the appropriation of the Company's 2025 net profit, including a total cash dividend
of US$87,000,000 to all shareholders. This comprises an interim dividend of US$42,000,000 (Rp28.4459 per
share) distributed on 28 November 2025, and a final dividend of US$45,000,000 (or equivalent to
approximately US$0.0018 per share) to be distributed on 3 July 2026.

The AGMS approved the appointment of Public Accounting Firm Purwanto, Susanti and Surja, registered with
the OJK, to audit the Balance Sheet, Profit and Loss Statement and other parts of the Consolidated Financial
Statements of the Company and its Subsidiaries for the financial year ending 31 December 2026.

Shareholders approved changes to the composition of the Company's Board of Commissioners and Board of
Directors as follows:

       Board of Commissioners
       Yani Y. Panigoro                            :            President Commissioner
       Yaser Raimi A. Panigoro                     :            Commissioner
       Roberto Lorato                              :            Commissioner
       Marsillam Simandjuntak                      :            Independent Commissioner
       Royke Tumilaar                              :            Independent Commissioner
       Board of Directors
       Hilmi Panigoro                              :            President Director
       Ronald Gunawan                              :            Director and Chief Executive Officer
       Amri Siahaan                                :            Director and Chief Operating Officer
       Benny Setiawan                              :            Director and Chief Financial Officer
       Sanjeev Bansal                              :            Director and Chief Growth Officer

 The AGMS approved the planned transfer of 150,000,000 (one hundred fifty million) treasury shares,
 representing a portion of the shares acquired under the 2025 Share Buyback, to support share ownership
 programs for employees and/or the Board of Directors and Board of Commissioners of the Company, its
 Subsidiaries and affiliates; and the amendment of Article 3 of the Company's Articles of Association regarding
 the Company's objectives and purposes to align it with the 2025 Indonesian Standard Industrial Classification
 (KBLI). (*)
 PT Medco Energi Internasional Tbk (“MedcoEnergi”) is a leading Southeast Asian energy and natural resources company listed on the Indonesia Stock Exchange
 (MEDC-IDX). MedcoEnergi has three key business segments, Oil & Gas, Power and Copper & Gold Mining. MedcoEnergi explores for and produces oil and gas
 primarily in Indonesia. The Group operates gas, PV, geothermal and hydro power plants in Indonesia through PT Medco Power Indonesia and has a non-consolidated
 interest in PT Amman Mineral Internasional Tbk which operates a large copper and gold mine in Indonesia.

 This document may contain projections, plans, strategies, policies and objectives of MedcoEnergi which should be treated as forward-looking statements within the
 meaning of applicable law. Forward-looking statements, by their nature, involve risks and uncertainties that could cause actual results to differ materially from those
 expressed or implied in these statements. The Company does not guarantee that any action taken in reliance on this document will bring specific results.

                                                                For further information please contact:
                                      Corporate Secretary | Investor Relations | Tel: (62-21) 2995 3000, Fax: (62-21) 2995 3001
                                       Email: corporate.secretary@medcoenergi.com | investor.relations@medcoenergi.com
                                                                  Website: www.medcoenergi.com